This rat study demonstrates that BPC-157 effectively prevents gentamicin-induced kidney damage by modulating the nitric oxide system, maintaining normal kidney function markers (urea, creatinine), preserving tubular structure, and reducing oxidative stress markers. The research uses a novel triple NO-agent approach to isolate BPC-157’s mechanism, showing it overwhelms harmful NO-system dysregulation. Findings suggest BPC-157 has robust nephroprotective properties relevant to practitioners managing drug-induced kidney toxicity or seeking renal support interventions.
For your business
BPC-157 preserved renal markers and tubular integrity in gentamicin-exposed rats via NO-system modulation, informing renal support discussions.